Pharmaceutical Industry
On July 1, 2014, Actavis completed the acquisition of Forest Laboratories, creating an innovative new model in specialty pharmaceuticals leadership built to compete within today’s evolving healthcare landscape. Learn more at www.Actavis.com
Actavis plc (NYSE:ACT), headquartered in Dublin, Ireland, is a unique specialty pharmaceutical company focused on developing, manufacturing and commercializing affordable generic and innovative branded pharmaceutical products for patients around the world.
The Company markets a broad portfolio of branded and generic pharmaceuticals and develops new medicines for
patients suffering from diseases principally in the central nervous system, gastroenterology, women’s health, urology, cardiovascular, respiratory and anti-infective therapeutic categories. The Company is an industry leader in product research and development, with one of the broadest brand development pipelines in the pharmaceutical industry, and a leading position in the submission of generic product applications. Actavis has commercial operations in more than 60 countries and operates more than 30 manufacturing and distribution facilities around the world. Additionally, the Company’s North American Brands commercial sales, marketing and drug development & research functions are located in our Jersey City, NJ offices.
Troyan • Bulgaria Bucharest • Romania
Owings Mills, MD • USA
Chennai • India Hafnarfjordur • Iceland
Bangalore • India
Jakarta • Indonesia Elizabeth, NJ • USA
Long Island, NY • USA Jersey City, NJ • USA Parsippany, NJ • USA
Oakland, CA • USA
Navi, Mumbai • India Salt Lake City, UT • USA
Weston, FL • USA
Miramar, FL • USA Ambernath • India
Nerviano • Italy
Dundalk • Ireland Larne • Northern Ireland
Liverpool • UK
London • UK
Liège • Belgium
Our Global Marketplace
Our World-Class R&D Organization
About Actavis
Actavis and Forest
• Participating in the creation, execution and management of clinical trials • Developing trial protocols and materials
• Training and managing investigative sites
• Analyzing, interpreting, and reporting clinical trial data
• Collaborating with a number of internal teams including Biostatistics, Data Management, Regulatory Affairs, Global Drug Safety, and Global Monitoring Operations
Our Clinical Development team is responsible for the development and execution of our global Phase II - IV clinical trials across our therapeutic categories. Team Fellows activities include:
Clinical Development
Now entering its 12th year, the Actavis Fellowship Program (formerly known as the Forest Research Institute Fellowship) is one of the most dynamic and challenging development programs in the industry. In partnership with St. John’s University College of Pharmacy and Health Sciences, we offer two 2-year fellowships focused in Regulatory Affairs and Clinical Development. Both programs are based in our Jersey City, New Jersey office and designed to offer a broad range of hands-on training and professional development opportunities.
Regulatory Affairs
Our Regulatory Affairs team leads our Company’s business-critical relationships with the U.S. Food and Drug Administration (FDA) and other regulatory agencies throughout the world, ensuring the continued success of our product portfolio and pipeline. Team Fellow activities include:
• Supporting the development, filing and regulatory approval of new products
• Filing and maintaining Investigational New Drug Applications (INDs) and New Drug Applications (NDAs) • Ensuring team compliance with all appropriate regulations and laws
2014-2015 Actavis Fellowship Program
Clinical Development (l-r) 1st row: P.Hornick, Vice President TA Head, M. Adams;
The Actavis Fellowship Program is unique in that it offers the opportunity for fellows to rotate to other functional teams during their second year, helping to accelerate their professional growth and broaden their industry experience. Possible second-year rotations (3-12 months in duration) include:
• Clinical Development • Global Drug Safety
• Global Monitoring Operations
• Health Economics and Outcomes Research • Marketing
• Medical Affairs
• New Products Market Research
• New Products Scientific Assessment • Project Management
• Quality Assurance/Compliance • Regulatory Affairs
• Regulatory Advertising/Promotion
• External rotations with the FDA are also permitted
St. John’s University College of Pharmacy and Health Sciences, located in Queens, NY, is affiliated and partners with a number of elite healthcare
organizations throughout the New York metropolitan area. Founded in 1929, the University offers undergraduate and graduate level healthcare-related programs. Undergraduates and graduates are actively involved in basic science, clinical research, and providing pharmaceutical care to an urban patient population.
St. John’s University Component
Fellows are full-time University employees and provided a competitive stipend and benefit package, including comprehensive health insurance. Each Fellow is required to complete a one-semester teaching component at the University during their first year and a collaborative research project by the end of the second year. Additionally, each Fellow is able to participate in a number of other professional and educational development opportunities at the University, including mentorships; presentations; continuing education courses; resident and fellow seminars; Affiliate Faculty appointments; and a teaching certificate course. Fellows may also enroll and participate in University courses and degree programs.
Certificate of Completion
Upon successful completion of the program, Fellows receive a certificate from St. John’s University College of Pharmacy and Health Sciences and Actavis.
ABOUT
ST. JOHN’S UNIVERSITY
Location: Queens, NY Dean: Russell J. DiGate, Ph.D. Graduate Programs Offered:
M.S./Ph.D. in Pharmaceutical Sciences;
M.S. in Biological and Pharmaceutical Biotechnology, Pharmacy Administration, and Toxicology; Master of Public Health (MPH) Website: www.stjohns.edu/academics/schools-and-colleges/college-pharmacy-and-health-sciences
St. John’s University College of
Pharmacy And Health Sciences
“The St. John’s component provides a venue not only to teach students in an academic setting, but also to work on public speaking and your presentation style. This experience has shown benefit far beyond the classroom, especially since conveying information is at the heart of the profession of pharmacy.”
– Joseph P. Stalder, PharmD Clinical Development Fellow
CURRENT FELLOWS
“The St. John’s/Forest Research Institute Fellowship gave me the skill sets necessary to achieve a successful career in the
pharmaceutical industry. The fast-paced, high-energy environment, paired with a very dedicated group of preceptors, afforded me a customized learning experience that provided the confidence necessary to seek high-profile challenging, and rewarding positions in the industry.”
– Amjad Iqbal, PharmD Regulatory Affairs Fellow 2004-2006
CLINICAL DEVELOPMENT
REGULATORY AFFAIRS
Maxwell Adams, PharmD
Massachusetts College of Pharmacy and Health Sciences University
Betsy Kurian, PharmD
St. John’s University
College of Pharmacy and Allied Health Professions
Omar Khalid, PharmD
St. John’s University, College of Pharmacy and Health Sciences
Reene Nadpara, PharmD
Rutgers University,
Ernest Mario School of Pharmacy
2013 - 2015
2013 - 2015 2014 - 2016
2014 - 2016
Our Industry-Leading Commitment to R&D
• 25+ specialty brand products in the near- or mid-term stage of development • ~12 product candidates at the Phase III or NDA stages of development• Alzheimer’s disease, cardiovascular disease, GI, infectious disease, Schizophrenia and bipolar disorders and COPD
2014-2015 Fellowship Team (l-r) 1st row: P. Hornick, A. Howell, L. Kunka, R. Nadpara, R. Masoud, A. Chan, N. Success, D. Maiden; 2nd row: R. Hofbauer, M. Adams, O. Khalid, A. Iqbal, D. Yuen, M. Olchaskey
2012 - 2014 2009 - 2011 2006 - 2008 2011 - 2013 2008 - 2010 2005 - 200 7 2010 - 2012 200 7 - 2009 200 4 - 2006
PAST FELLOWS
CLINICAL DEVELOPMENT
REGULATORY AFFAIRS
Albany College of Pharmacy and Health Sciences
The Ohio State University
Yunji Kim, PharmD
Associate Manager, Regulatory Affairs, Regeneron Pharmaceuticals
University of North Carolina at Chapel Hill, Eshelman School of Pharmacy
Donato M. Forlenza, PharmD, MBA
Manager, Regulatory Affairs, Advertising and Promotion Compliance, Boehringer Ingelheim Pharmaceuticals
Jessica Kachadourian, PharmD
Associate Director, Medical Affairs Novartis
Northeastern University
Julie Plotnikov, PharmD
Product Manager LEO Pharma A/S
Temple University School of Pharmacy
Rachel Luchini, PharmD
Sr. Clinical Scientist, Clinical Development Forest Research Institute, Inc.
Rutgers University, Ernest Mario School of Pharmacy
Sejal P. Emerson, PharmD
Director, Regulatory Affairs AbbVie
University of Michigan, College of Pharmacy
Kerri Z. Kaplan, PharmD
Associate Director, Regulatory Affairs Dompé
Long Island University, Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Shweta Pandya, PharmD
Manager, Advertising and Promotion, Regulatory Affairs
Forest Research Institute, Inc.
St. John’s University,
College of Pharmacy and Allied Health Professions
Peter J. McFarland, PharmD
Medical Science Liaison, Teva Pharmaceuticals
Massachusetts College of Pharmacy and Health Sciences
Hiren D. Patel, PharmD, MS, RAC LCDR USPHS
Regulatory Health Project Manager Division of Psychiatry Products
Center For Drug Evaluation and Research, FDA
St. John’s University,
College of Pharmacy and Allied Health Professions
Vincent C. Yan, PharmD
Senior Marketing Manager Amgen
Rutgers University, Ernest Mario School of Pharmacy
Amjad Iqbal, PharmD
Director, Regulatory Affairs Forest Research Institute, Inc.
University of Cincinnati, College of Pharmacy
Joseph P. Stalder, PharmD
Principal Business Manager Genentech
University of California, San Diego
Nicole L. Bradley, PharmD
Regulatory Health Project Manager Division of Neurology Products
Center for Drug Evaluation and Research, FDA
Karen A. Allen, PharmD
Manager, Quality Assurance GCP GLP CSPV Daiichi Sankyo, Inc.
St. John’s University,
College of Pharmacy and Allied Health Professions
Hilary Winters Henshaw, PharmD
Associate Regulatory Program Director Product Development, Genentech
University of Michigan, College of Pharmacy
Michael C. Camuso, PharmD
Senior Pharmacist, Investigational Drug Services, Brigham and Women’s Hospital
Albany College of Pharmacy and Health Sciences
Amol J. Parekh, PharmD
Principal Associate, Regulatory Affairs Genzyme, a Sanofi Company
Application Process and Eligibility Requirements
Application Deadlines
Curriculum Vitae (Resume) December 17, 2014 Letter of Intent December 17, 2014 Official College Transcript December 22, 2014 Letters of Recommendation (3) December 22, 2014
To be considered for the Actavis Fellowship Program, you must meet the following requirements:
• Graduate of an Accreditation Council for Pharmacy Education (ACPE)-accredited Doctor of Pharmacy Program prior to the start of the fellowship term
• Have a strong interest in pursuing a career in the pharmaceutical industry Interviews begin Saturday, December 7th, 2014 at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Anaheim, California. Candidates are encouraged to set up an interview in advance by emailing Dr. Joseph Brocavich at brocavij@stjohns.edu.
Electronic Copies Should Be Sent To: Dr. Joseph Brocavich: brocavij@stjohns.edu.
Dr. Michael Olchaskey: PharmDFellowship@frx.com Hard Copies Should Be Mailed to:
Joseph M. Brocavich, PharmD Senior Associate Dean for Pharmacy Associate Clinical Professor
College of Pharmacy and Health Sciences St. John’s University
8000 Utopia Parkway Queens, NY 11439
For more information about our Fellowship Program, contact the current Fellows at PharmDFellowship@frx.com or visit:
